A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report
Author(s) -
S.K. Goswami
Publication year - 2004
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deh359
Subject(s) - letrozole , ovulation , medicine , pregnancy rate , follicular phase , ovarian reserve , embryo transfer , gynecology , pregnancy , follicle stimulating hormone , randomized controlled trial , ovulation induction , live birth , andrology , in vitro fertilisation , gonadotropin , aromatase , infertility , luteinizing hormone , biology , hormone , breast cancer , cancer , genetics
Use of letrozole, a selective inhibitor of aromatase, reduces the gonadotrophin dose required to induce follicular maturation. We evaluated whether incorporation of letrozole could be an effective low-cost IVF protocol for poor responders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom